title: Cutaneous adverse drug reaction associated with oral temozolomide presenting as dermal and subcutaneous plaques and nodules.
authors.affiliation: Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Pooja
authors.initials: P
authors.lastname: Virmani
authors.affiliation: Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Esther
authors.initials: E
authors.lastname: Chung
authors.affiliation: Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Alissa A
authors.initials: AA
authors.lastname: Thomas
authors.affiliation: Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Pharmacology, Weill-Cornell Graduate School of Biomedical Sciences, New York, New York.
authors.forename: Ingo K
authors.initials: IK
authors.lastname: Mellinghoff
authors.affiliation: Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Michael A
authors.initials: MA
authors.lastname: Marchetti
keywords: ADR, adverse drug reaction; TMZ, temozolomide; adverse drug reaction; dermal hypersensitivity reaction; panniculitis; rash; temozolomide